Salvia Investment Gmbh
At a glance: Salvia Investment Gmbh is 10% Owner at Bambusa Therapeutics (BBTX). Their latest SEC Form 4, filed Nov 2, 2026, reported a purchase of $6.0M. On file: 1 purchase line ($6.0M) and 0 sale lines ($0).
10% Owner at Bambusa Therapeutics, Inc. (BBTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$6.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 2 NewSEC | BBTXBambusa Therapeutics, Inc. | Buy | 375,0009,264,301 held (+4%) | $16.00 | $6.0M | — |
- Buy
10% Owner Investment Gmbh Salvia bought $6.0M of BBTX at $16.00 — first open-market purchase in our records.